ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Harvard-led researchers silenced ALDH3B2 in human ductal cells, raising beta-like conversion from under 1 percent to about 8.5 percent. Transplanted into diabetic mice, the cells produced human insulin and lowered glucose to near-normal for six weeks. The work, published in Science Translational Medicine, suggests reprogramming existing pancreatic cells rather than replacing them.
Tap to vote and see what everyone thinks.
Summary by ByteBrief